<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-5696</issn><issn publication-format="electronic">2079-5831</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">28549</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">HPV associated diseases and women's quality of life</article-title><trans-title-group xml:lang="ru"><trans-title>ВПЧ-ассоциированные заболевания и качество жизни женщин</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sycheva</surname><given-names>E G</given-names></name><name xml:lang="ru"><surname>Сычева</surname><given-names>Е Г</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач научно-поликлинического отд-ния ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>el.bona@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nazarova</surname><given-names>N M</given-names></name><name xml:lang="ru"><surname>Назарова</surname><given-names>Н М</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, вед. науч. сотр. научно-поликлинического отд-ния ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>grab2@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Prilepskaya</surname><given-names>V N</given-names></name><name xml:lang="ru"><surname>Прилепская</surname><given-names>В Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф., зам. дир., рук. научно-поликлинического отд-ния ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bourmenskaya</surname><given-names>O V</given-names></name><name xml:lang="ru"><surname>Бурменская</surname><given-names>О В</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р биол. наук, науч. сотр. лабораторно- генетических методов ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>o_bourmenskaya@oparina4.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Frankevich</surname><given-names>V E</given-names></name><name xml:lang="ru"><surname>Франкевич</surname><given-names>В Е</given-names></name></name-alternatives><bio xml:lang="ru"><p>кaнд. физ.-мат. наук, зав. отделом системной биологии в репродукции ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>v_frankevich@oparina4.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-08-15" publication-format="electronic"><day>15</day><month>08</month><year>2016</year></pub-date><volume>18</volume><issue>4</issue><issue-title xml:lang="en">VOL 18, NO4 (2016)</issue-title><issue-title xml:lang="ru">ТОМ 18, №4 (2016)</issue-title><fpage>39</fpage><lpage>44</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://gynecology.orscience.ru/2079-5831/article/view/28549">https://gynecology.orscience.ru/2079-5831/article/view/28549</self-uri><abstract xml:lang="en"><p>Human papillomavirus is likely the most common sexually transmitted viral infection worldwide. HPV provokes anogenital diseases and genital warts. It should be noted the specific importance of the quality of life assessment of the women with human papillomavirus - associated cervical diseases.</p></abstract><trans-abstract xml:lang="ru"><p>Папилломавирусная инфекция - наиболее распространенная инфекция, передаваемая половым путем. Вирус папилломы человека является причиной предраковых заболеваний аногенитальной области и экзофитных кондилом. Следует отметить особую важность оценки качества жизни у женщин с вирусом папилломы человека - ассоциированными заболеваниями шейки матки.</p></trans-abstract><kwd-group xml:lang="en"><kwd>human papillomavirus</kwd><kwd>cervical intraepithelial neoplasia</kwd><kwd>cervical cancer</kwd><kwd>quality of life</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вирус папилломы человека</kwd><kwd>цервикальные интраэпителиальные неоплазии</kwd><kwd>рак шейки матки</kwd><kwd>качество жизни</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Massad L.S, Einstein M.H, Huh W.K et al. ASCCP Consensus Guidelines Conference (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2012; 121 (4): 829-46.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Петрова Г.В., Каприн А.Д., Старинский В.В., Грецова О.П. Заболеваемость онкологическими заболеваниями населения России. Онкология. Журн. им. П.А.Герцена. 2014; 5: 5-10.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Новик А.А., Ионова Т.И., Кайнд П. Концепция исследования качества жизни в медицине. СПб.: Элби, 1999.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Waxman A.G, Chelmow D, Darragh T.M et al. Revised Terminology for Cervical Histopathology and Its Implications for Management of High - Grade Squamous Intraepithelial Lesions of the Cervix. Obstet Gynecol 2012; 120 (6): 1465-71.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Guan P, Howell-Jones R, Li N et al. Human papillomavirus types in 115,789 HPV-positive women: A meta - analysis from cervical infection to cancer. Int J Cancer 2012 Feb 9.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Formana D, de Martelb C, Laceyc C.J et al. Global Burden of Human Papillomavirus and Related Diseases. Vaccine 2012; 30: 12-23.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Marcellusi A, Sc M, Capone A et al. Health Utilities lost and risk factors associated with HPV-induced diseases in men and women: The HPV Italian collaborative study group. Clin Ther 2015; 37 (1): 156-67.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Lang H.C, Chuang L, Shun S.C et al. Validation of EQ-5D in patients with cervical cancer in Taiwan. Support Care Cancer 2010; 18: 1279-86.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Waxman A.G, Chelmow D, Darragh T.M et al. Revised Terminology for Cervical Histopathology and Its Implications for Management of High - Grade Squamous Intraepithelial Lesions of the Cervix. Obstet Gynecol 2012; 120 (6): 1465-71.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Murasawa H, Konno R, Okubo I et al. Evaluation of health - related quality of life for hypothesized medical states associated with cervical cancer. Asian Pac J Cancer Prev 2014; 15 (22): 9679-85.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Mc Caffery K, Waller J, Forrest S et al. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004; 111 (12): 1437-43.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Maissi E, Marteau T.M, Hankins M et al. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ 2004; 328 (7451): 1293.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Bertram C.C, Magnussen L. Informational needs and the experiences of women with abnormal Papanicolaou smears. J Am Acad Nurse Pract 2008; 20 (9): 55-62.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Waller J, Mc Caffery K, Kitchner H et al. Women’s experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study. Psycho - Oncology 2007; 16: 196-204.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Petry K.U. HPV and cervical cancer. Scand J Clin Lab Invest Suppl 2014; 244: 59-62.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ball S.L, Winder D.M, Vaughan K et al. Analysis of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol 2011; 83: 1345-50.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Meyer T, Arndt R, Christophers E et al. Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infec Dis 1998; 178: 252-5.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Brown D.R, Schroeder J.M, Bryan J.M et al. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999; 37: 3316-22.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Monteiro E.F, Lacey C.J.N, Merrick D. The interrelationship of demographic and geospatial risk factors between four common sexually transmitted diseases. Sex Transm Infect 2005; 81: 41-6.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Bruni L, Diaz M, Castellsagué X et al. Cervical human papillomavirus prevalence in 5 continents: meta - analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202: 1789-99.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>O’Mahony C. Genital warts: current and future management options. Am J Clin Dermatol 2005; 6: 239-43.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Wang H, Qiao Y.L. Human papillomavirus type - distribution in condylomata acuminata of mainland China: a meta - analysis. Int J STD 2008; 19: 680-4.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Ju-Fang Shi, Dian-Ju Kang, Shu-Zhen Qi et al. Impact of genital warts on health related quality of life in men and women in mainland China: a multicenter hospital - based cross - sectional study. BMC Public Health 2012; 12: 153-62.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Rabin R, de Charro F. EQ-5D: a measure of health status from the Euro Qol Group. Ann Med 2001; 33: 337-43.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>American Society for Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1996; 14 (3): 671-9.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Zhi-Mei Zhao, Xiong-Fei Pan, Si-Han Let al. Quality of life in women with cervical precursor lesions and cancer: a prospective, 6-month, hospital - based study in China. Chin J Cancer 2014; 33 (7): 339-45.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Endarti D, Riewpaiboon A, Thavorncharoensap M et al. Evaluation of Health - Related Quality of Life among Patients with Cervical Cancer in Indonesia. Asian Pac J Cancer Prev 2015; 16 (8): 3345-50.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Busija L, Pausenberger E, Haines T.P et al. Adult measures of general health and health - related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well - Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care Res (Hoboken) 2011; 63 (11): 383-412.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Young T.A, Mukuria C, Rowen D et al. Mapping Functions in Health - Related Quality of Life: Mapping from Two Cancer - Specific Health - Related Quality - of - Life Instruments to EQ-5D-3L. Med Decis Making 2015; 35 (7): 912-26.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Cheung Y.B, Goh C, Thumboo J et al. Variability and sample size requirements of quality - of - life measures: a randomized study of three major questionnaires. J Clin Oncol 2005; 23 (22): 4936-44.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Wang W, Ski C.F, Thompson D.R, Hare D.L. A psychometric evaluation of the Chinese version of the short - form cardiac depression scale. Psychosomatics 2011; 52 (5): 450-4.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Chen Y.W, Coxson H.O, Reid W.D. Reliability and Validity of the Brief Fatigue Inventory and Dyspnea Inventory in People With Chronic Obstructive Pulmonary Disease. J Pain Symptom Manage 2016; 3924 (16): 301-14.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Wang J, Lu S, Zhao S. Post - infectious and non post - infectious irritable bowel syndrome: A comparative study. Pak J Med Sci 2016; 32 (1): 116-9.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Paes F.G, Salgado Filho N, Neto da Silva M.A et al. Effect of urinary incontinence on the quality of life of asthmatic women. J Asthma 2016; 53 (5): 553-8.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Gagnon L.H, Boucher J, Robert M. Impact of pelvic floor muscle training in the postpartum period. Int Urogynecol J 2016; 27 (2): 255-60.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Wang W, Chow A, Thompson D.R et al. Predictors of Health - Related Quality of Life Among Patients With Myocardial Infarction. West J Nurs Res 2016; 38 (1): 43-56.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Mc Donough C.M, Grove M.R, Elledge A.D, Tosteson A.N. Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire. Osteoporos Int 2012; 23 (2): 723-32.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Gauffin E, Öster C, Sjöberg F et al. Health - related quality of life (EQ-5D) early after injury predicts long - term pain after burn. Burns 2016; 21: 301-67.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Caruso S, Cianci S, Cariola M et al. Effects of nutraceuticals on quality of life and sexual function of perimenopausal women. J Endocrinol Invest 2016 Jun 14.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Katainen R.E, Engblom J.R, Siirtola T.J et al. Climacteric symptoms in middle - aged women with chronic somatic diseases. Maturitas 2016; 86: 17-24.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Bjelic-Radisic V, Jensen P.T, Vlasic K.K, Waldenstrom A-C. Quality of life characteristics in patients with cervical cancer. Eur J Cancer 2012; 48: 3009-18.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Ашрафян Л.А., Киселев В.И. Опухоли репродуктивных органов (этиология и патогенез). М.: Дмитрейд График Групп, 2008; с. 216.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Прилепская В.Н. Заболевания шейки матки, влагалища, вульвы. М.: МЕДпресс - информ, 2005.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Роговская С.И. Папилломавирусная инфекция у женщин и патология шейки матки: в помощь практикующему врачу. Изд. 2-е. М.: ГЭОТАР-Медиа, 2008.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Saslow D еt al. American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. CA Cancer J Clin 2002; 52: 342-62.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Ho G.Y.F, Bierman R, Beardsley L et al. Natural history of cervicovaginal HPV infections in young women. NEJM 1998; 338: 423-8.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Кулаков В.И., Прилепская В.Н., Паавонен Й. Профилактика рака шейки матки: руководство для врачей. М.: МЕДпресс - информ, 2008.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Сухих Г.Т., Прилепская В.Н. Профилактика рака шейки матки: руководство для врачей. Изд. 3-е. М.: МЕДпресс - информ, 2012.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Мынбаев О.А., Елисеева М.Ю., Доорбар Дж., Манухин И.Б. Эпидемиология, молекулярная биология, патофизиология и принципы иммунотерапии папилломавирусной инфекции. Вопр. гинекологии, акушерства и перинатологии. 2009; 8 (3): 69-79.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Прилепская В.Н., Роговская С.И. Возможности Изопринозина в лечении хронических цервицитов и вагинитов. Рус. мед. журн. 2008; 16 (1): 5-9.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Кедрова А.Г., Леваков С.А., Челнокова Н.Н. и др. Роль профилактических осмотров и первичного приема врача в женской консультации в выявлении субклинических и латентных форм папилломавирусной инфекции шейки матки и их мониторинг//Гинекология. 2011; 13 (1): 56-62.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Клинышкова Т.В., Каратюк Т.И., Турчанников Д.В. Дифференцированный подход к ведению больных с цервикальной интраэпителиальной неоплазией с позиции прогнозирования//Гинекология. 2011; 13 (4): 6-40.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Костава М.Н., Прилепская В.Н. Возможности терапии папилломавирусной инфекции. Рус. мед. журн. 2009; 17 (1): 9-16.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Шварц Г.Я., Прилепская В.Н, Мынбаев О.А. Изопринозин в лечении папилломавирусной инфекции в гинекологической практике. М., 2011.</mixed-citation></ref></ref-list></back></article>
